Shchehlov D, Bortnik I, Svyrydiuk O, Vyval M, Gunia D
1State Organization "Scientific-Practical Center of Endovascular Neuroradiology NAMS of Ukraine", Kiev, Ukraine.
v1State Organization "Scientific-Practical Center of Endovascular Neuroradiology NAMS of Ukraine", Kiev, Ukraine.
Georgian Med News. 2019 May(290):38-44.
The association of cerebral arteriovenous malformations (bAVM) and associated paranidal aneurysms, that is closely related to the AVM nidus, carry a high risk of rapture and re-rapture after initial hemorrhage. This association is consider as therapeutic challenge and supportive data about their natural history and best treatment modalities are still lacking. In this article we report our experience of their treatment. We reviewed 443 cases of patients with AVMs between 2004 and 2018, who were treated at our institution and found 73 (16,5%) cases of AVM association with paranidal aneurysms (22 (30,2%) arterial - prenidal, 20 (27,4%) intranidal, and 19 (26,0%) venous - postnidal). Twelve (16,4 %) patients had multiple aneurysm. All patients received endovascular treatment with n-butyl cyanoacrylate (NBCA), ONYX or Embolin embolization. We evaluated clinical and radiological data, treatment and outcomes at discharge. Among 73 patients (32 (43,8 %) women and 41 (56,2 %) men, mean age - 34 years, 8 - 65 years) with AVM and paranidal aneurysms who were enrolled in our study, hemorrhage was the most frequent presenting symptom (47 patients (64.4%). The timing of procedure varied between 3 - 23 days. Total occlusion of AVM was achieved in 23 (31,5%) cases, in all other cases partial or target occlusion with obligatory aneurysm embolization was done. Seven (9,6%) patients had complication (5 ischemic and 2 hemorrhagic) after procedure. Clinical improvement was seen in all groups at discharge. Mean change of mRS score between admission and discharge was 0,2-0,5 point. Excellent or good outcome (mRS - 0,1,2) was observed in 58 (79,5%) patients at discharge. Unfavorable outcome (mRS - 3-5) had 13 (17,8%) patients, mRS - 6 - 2 (2,7%) patients. Patients sustaining AVM and multiple paranidal aneurysms had higher risk of hemorrhage comparing with single one (OR-17,5 (95% CI -1,0-309,8 (p=0,010). Relationship between AVM with paranidal aneurysms and hemorrhagic presentation is obvious, however definite source of hemorrhage is difficult to evaluate. To our belief arterial prenidal and intranidal aneurysms especially multiple are the most dangerous and should be in therapeutic focus after it's finding. Endovascular embolization has the potential to be effective and safe in treatment of AVM with paranidal aneurysms.
脑动静脉畸形(bAVM)与相关的瘤旁动脉瘤的关联与AVM病灶密切相关,在初次出血后破裂和再次破裂的风险很高。这种关联被视为治疗挑战,关于其自然病史和最佳治疗方式的支持性数据仍然缺乏。在本文中,我们报告了我们对其治疗的经验。我们回顾了2004年至2018年间在我们机构接受治疗的443例AVM患者,发现73例(16.5%)AVM合并瘤旁动脉瘤(22例(30.2%)动脉性 - 瘤前,20例(27.4%)瘤内,19例(26.0%)静脉性 - 瘤后)。12例(16.4%)患者有多个动脉瘤。所有患者均接受了用氰基丙烯酸正丁酯(NBCA)、Onyx或Embolin进行的血管内栓塞治疗。我们评估了临床和放射学数据、治疗及出院时的结果。在我们研究纳入的73例患有AVM和瘤旁动脉瘤的患者中(32例(43.8%)女性和41例(56.2%)男性,平均年龄 - 34岁,8 - 65岁),出血是最常见的首发症状(47例患者(64.4%))。手术时间在3 - 23天之间。23例(31.5%)病例实现了AVM的完全闭塞,在所有其他病例中进行了部分或靶向闭塞并强制性栓塞动脉瘤。7例(9.6%)患者术后出现并发症(5例缺血性和2例出血性)。出院时所有组均有临床改善。入院和出院之间改良Rankin量表(mRS)评分的平均变化为0.2 - 0.5分。出院时58例(79.5%)患者观察到良好或优秀的结果(mRS - 0、1、2)。13例(17.8%)患者有不良结果(mRS - 3 - 5),2例(2.7%)患者mRS - 6。与单个瘤旁动脉瘤相比,患有AVM和多个瘤旁动脉瘤的患者出血风险更高(比值比 - 17.5(95%可信区间 - 1.0 - 309.8(p = 0.010))。AVM与瘤旁动脉瘤和出血表现之间的关系很明显,然而出血的确切来源很难评估。我们认为动脉性瘤前和瘤内动脉瘤尤其是多个动脉瘤是最危险的,在发现后应成为治疗重点。血管内栓塞在治疗伴有瘤旁动脉瘤的AVM方面有可能有效且安全。